Hjem › Ulcerøs kolitt › Michigan
Kliniske studier for Ulcerøs kolitt i Michigan
17 studier for Ulcerøs kolitt søker deltakere på steder i Michigan.
Byer i Michigan
Offisiell studietekst (engelsk)
Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
- University of Michigan, Ann Arbor
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07501078Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287), Ypsilanti
RekruttererFase 3
Alle aldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06651281Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- West Michigan Clinical Research Center /ID# 280480, Wyoming
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
- Huron Gastro, Ypsilanti
RekruttererFase 4
Alder 18 til 80 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06581328A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06598943LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Clinical Research Institute of Michigan, LLC, Clinton Township
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07483073LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Huron Gastroenterology Associates, P.C., Ypsilanti
RekruttererFase 4
Alder 18 til 65 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan - Site Number: 8400060, Wyoming
RekruttererFase 3
Alder 16 til 80 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07185009A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Michigan Center of Medical Research, Farmington Hills
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan - Site Number: 8400060, Wyoming
RekruttererFase 3
Alder 16 til 80 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07184996A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital of Michigan, Detroit
RekruttererFase 3
Alder 2 til 17 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06100289Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
- University of Micigan, Ann Arbor
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jul. 2026 · NCT07456566A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- William Beaumont Hospital/Corewell Health - East, Royal Oak
- William Beaumont Hospitals Reference Laboratory, Royal Oak
RekruttererFase 2
Alder 12 til 17 · Alle kjønn · Oppdatert 8. jul. 2026 · NCT05287126A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Childrens Hospital of Michigan, Detroit
RekruttererFase 3
Alder 2 til 17 · Alle kjønn · Oppdatert 22. jun. 2026 · NCT06405087A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Ypsilanti
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 12. mar. 2026 · NCT07113522Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.